Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui Yi Xue

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
AAPS Pharmscitech|April 2, 2014
Nanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutionsMayuri Narvekar, Hui Yi Xue, June Young Eoh, et al.
Pharmaceutical Research|November 9, 2012
Lipid encapsulation of cationic polymers in hybrid nanocarriers reduces their non-specific toxicity to breast epithelial cellsHui Yi Xue, Mayuri Narvikar, Juan-Bao Zhao, et al.
International Journal of Pharmaceutics|April 27, 2021
Development of a high payload, cancer-targeting liposomes of methyl aminolevulinate for intraoperative photodynamic diagnosis/therapy of peritoneal carcinomatosisShijie Luan, Ngoc T Tran, Hui-Yi Xue, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 13, 2014
A new nanostructured carrier design including oil to enhance the pharmaceutical properties of retinoid therapy and its therapeutic effects on chemo-resistant ovarian cancerMayuri Narvekar, Hui Yi Xue, Ngoc T Tran, et al.
International Journal of Pharmaceutics|December 27, 2025
Bone-targeting lipid-polymer hybrid nanoparticles for less invasive, injectable local antibiotic treatment of bone infections by methicillin-resistant Staphylococcus aureus (MRSA)Pengbo Guo, Bettina A Buttaro, Hui Yi Xue, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 3, 2020
Incorporation of docosahexaenoic acid (DHA) enhances nanodelivery of antiretroviral across the blood-brain barrier for treatment of HIV reservoir in brainPengbo Guo, Mengjie Si, Di Wu, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 27, 2020
Lipid-polymer hybrid nanoparticles carrying linezolid improve treatment of methicillin-resistant Staphylococcus aureus (MRSA) harbored inside bone cells and biofilmsPengbo Guo, Bettina A Buttaro, Hui Yi Xue, et al.
International Journal of Pharmaceutics|September 3, 2020
Enhanced eradication of intracellular and biofilm-residing methicillin-resistant Staphylococcus aureus (MRSA) reservoirs with hybrid nanoparticles delivering rifampicinPengbo Guo, Hui Yi Xue, Bettina A Buttaro, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 12, 2016
Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectivesRui Xue Zhang, Ho Lun Wong, Hui Yi Xue, et al.
Journal of Pharmaceutical Sciences|March 26, 2016
Methocel-Lipid Hybrid Nanocarrier for Efficient Oral Insulin DeliveryMariam Boushra, Sozan Tous, Gihan Fetih, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
AAPS Pharmscitech|April 2, 2014
Nanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutionsMayuri Narvekar, Hui Yi Xue, June Young Eoh, et al.
Pharmaceutical Research|November 9, 2012
Lipid encapsulation of cationic polymers in hybrid nanocarriers reduces their non-specific toxicity to breast epithelial cellsHui Yi Xue, Mayuri Narvikar, Juan-Bao Zhao, et al.
International Journal of Pharmaceutics|April 27, 2021
Development of a high payload, cancer-targeting liposomes of methyl aminolevulinate for intraoperative photodynamic diagnosis/therapy of peritoneal carcinomatosisShijie Luan, Ngoc T Tran, Hui-Yi Xue, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 13, 2014
A new nanostructured carrier design including oil to enhance the pharmaceutical properties of retinoid therapy and its therapeutic effects on chemo-resistant ovarian cancerMayuri Narvekar, Hui Yi Xue, Ngoc T Tran, et al.
International Journal of Pharmaceutics|December 27, 2025
Bone-targeting lipid-polymer hybrid nanoparticles for less invasive, injectable local antibiotic treatment of bone infections by methicillin-resistant Staphylococcus aureus (MRSA)Pengbo Guo, Bettina A Buttaro, Hui Yi Xue, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 3, 2020
Incorporation of docosahexaenoic acid (DHA) enhances nanodelivery of antiretroviral across the blood-brain barrier for treatment of HIV reservoir in brainPengbo Guo, Mengjie Si, Di Wu, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 27, 2020
Lipid-polymer hybrid nanoparticles carrying linezolid improve treatment of methicillin-resistant Staphylococcus aureus (MRSA) harbored inside bone cells and biofilmsPengbo Guo, Bettina A Buttaro, Hui Yi Xue, et al.
International Journal of Pharmaceutics|September 3, 2020
Enhanced eradication of intracellular and biofilm-residing methicillin-resistant Staphylococcus aureus (MRSA) reservoirs with hybrid nanoparticles delivering rifampicinPengbo Guo, Hui Yi Xue, Bettina A Buttaro, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 12, 2016
Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectivesRui Xue Zhang, Ho Lun Wong, Hui Yi Xue, et al.
Journal of Pharmaceutical Sciences|March 26, 2016
Methocel-Lipid Hybrid Nanocarrier for Efficient Oral Insulin DeliveryMariam Boushra, Sozan Tous, Gihan Fetih, et al.
Pageof 3